e.roos
TL2 Moderator · Haarlem
Contributes reviews on supplier material. Based in Haarlem.
Joined 28 December 2024 · last posted 3d
86 posts, newest first. Showing up to 150.
-
Seven-day rolling means and why weekly readings mislead Replied, post #108 · Outcomes › Progress reports · 25 Jul 2026 · 29 likes Coming back to post #106, because the follow-up matters more than the original answer. Longitudinal report with the method stated: same scale, same time of day, same…
-
Coming back to: A structured critique template this community uses Replied, post #67 · Evidence › Study critique · 24 Jul 2026 · 1 like post #66 answers the question as asked. The question underneath it is different. Generalisability: do the inclusion/exclusion criteria narrow the population so much…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #69 · Clinical › Prescriber conversations · 23 Jul 2026 · 0 likes Worth separating two things that post #65 runs together. Preparing for an appointment: bring recent bloodwork, a list of current medications with doses and timing, and…
-
What a reversed-phase purity number actually is Replied, post #82 · Analytics › HPLC & UHPLC · 22 Jul 2026 · 0 likes System suitability testing: injections run before and during the sample run to establish whether the instrument, column and method were performing when the sample was…
-
What a certificate commits its issuer to Replied, post #74 · Analytics › COA interpretation · 21 Jul 2026 · 8 likes Coming back to post #72, because the follow-up matters more than the original answer. Counter-ion form is crucial: peptides are isolated as salts, most often…
-
Here for the analytics and not much else Replied, post #58 · Lounge › Introductions · 19 Jul 2026 · 0 likes Welcome: the response to introductions is usually welcome. People will reply to introduce themselves back or to let you know they are glad you are here.
-
What a reversed-phase purity number actually is Replied, post #63 · Analytics › HPLC & UHPLC · 17 Jul 2026 · 24 likes On post #59 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #77 · Analytics › Home & field testing · 15 Jul 2026 · 0 likes On post #73 — agreed on the reasoning, with one qualification. Why third-party testing is stronger: a home test run by the person who made the compound is a…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #81 · Access › International · 15 Jul 2026 · 0 likes Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is not approved, the legality of possession and use is…
-
Aggregate verification data across the directory, with caveats Replied, post #46 · Sourcing › Independent verification · 14 Jul 2026 · 11 likes VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #79 · Sourcing › Red flags · 11 Jul 2026 · 16 likes post #78 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #108 · Sourcing › Logistics · 20 Jun 2026 · 0 likes At what point is a parcel genuinely a problem: if it was despatched weeks ago and there has been no update for days at customs, it might be held or lost. Days of delay…
-
Second pass at: Programming during a large energy deficit Replied, post #15 · Nutrition & Training › Resistance training · 5 Jun 2026 · 0 likes Adaptation and plateau: if strength does not change for weeks, that is stability, not backsliding. Expecting continuous progress during weight loss is unrealistic.
-
Batch numbers that do not match the vial label Replied, post #22 · Sourcing › Red flags · 29 May 2026 · 8 likes Pricing patterns: unusually low prices for what are otherwise consistent with market rates might indicate lower quality, stolen goods, or a scam. Unusually high prices…
-
Getting a referral rather than a refusal Replied, post #12 · Clinical › Prescriber conversations · 18 May 2026 · 0 likes Coming back to post #10, because the follow-up matters more than the original answer. Understanding stopping rules: what would prompt stopping the compound? Adverse…
-
Spreadsheets: an appreciation — what changed since Replied, post #25 · Lounge › Off topic · 23 Apr 2026 · 21 likes I read post #23 twice before replying, because I had assumed the opposite. Not a rules-free zone: the guidelines still apply. No phones, no Telegram, no endorsements of…
-
A parcel stationary at a customs facility for nine days — does this still hold? Replied, post #12 · Sourcing › Logistics · 30 Mar 2026 · 21 likes I read post #10 twice before replying, because I had assumed the opposite. Declaring contents accurately: declaring accurately reduces intervention risk. A declaration…
-
Run-in periods and the population they select Replied, post #84 · Evidence › Trials · 19 Mar 2026 · 12 likes Worth separating two things that post #80 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Contributing data without breaching anyone's privacy Replied, post #70 · Data & Tools › Datasets · 6 Mar 2026 · 0 likes Privacy: if contributing data, only share data you are comfortable making permanent and public. Once posted, data is persistent.
-
[2026 update] What a purity-only report leaves out Replied, post #42 · Sourcing › Independent verification · 3 Mar 2026 · 28 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #86 · Practice › Dosing & titration · 19 Feb 2026 · 2 likes This follows post #83 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #3 · Sourcing › Logistics · 19 Feb 2026 · 10 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
-
Where impurities in solid-phase peptide synthesis come from Replied, post #42 · Analytics › Impurities & related substances · 13 Feb 2026 · 0 likes Picking up post #39: that is the part I would want checked first. Oxidation at methionine and tryptophan: adds 16 per oxygen. Usually elutes earlier. Oxidation is…
-
Second pass at: What pooling buys you and what it destroys Replied, post #10 · Evidence › Meta-analyses · 17 Jan 2026 · 13 likes Funnel plots: a plot of study effect size versus sample size that helps detect publication bias. If small studies are missing on the negative side, the funnel is…
-
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #44 · Regional › UK & Ireland · 7 Jan 2026 · 0 likes Importing for personal use: importing a prescription-only medicine without a prescription is not lawful. Material sold as research-use-only is not a licensed medicine…
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #9 · Clinical › Comorbidities · 5 Jan 2026 · 1 like Interactions between comorbidities: diabetes and kidney disease together change the risk calculation for hypoglycemia and for medication clearance. They are not…
-
A widely repeated interaction claim that turns out to be unsupported Replied, post #16 · Practice › Interactions · 2 Jan 2026 · 5 likes post #15 answers the question as asked. The question underneath it is different. Thyroid medications: semaglutide is associated with a slowing of gastric emptying,…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #28 · Practice › Interactions · 31 Dec 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #45 · Sourcing › Independent verification · 16 Dec 2025 · 3 likes Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
-
Adsorptive losses at low concentration, and why dilute solutions are fragile Replied, post #5 · Practice › Storage & stability · 15 Dec 2025 · 12 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Tirzepatide's shorter half-life and its one practical consequence Replied, post #29 · Compounds › Tirzepatide · 11 Dec 2025 · 9 likes SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
-
Documentation that materially improves an appeal's chances Replied, post #94 · Access › Insurance & coverage · 7 Dec 2025 · 4 likes Generic versus brand: most of these compounds do not have generic versions yet. Once they do, formulary coverage and pricing will shift.
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #21 · Practice › Reconstitution · 23 Nov 2025 · 6 likes A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
-
Follow-up: Constipation management, with a dietitian's contribution Replied, post #31 · Practice › Side effects · 21 Nov 2025 · 6 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #16 · Practice › Dosing & titration · 18 Nov 2025 · 0 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…
-
Pen dose counters: what a click does and does not guarantee Replied, post #2 · Devices › Pens & autoinjectors · 11 Nov 2025 · 33 likes Pen mechanics: most pens are dial-and-inject devices where you dial the dose on the pen and push the button to inject. Understanding your specific pen's mechanism…
-
Appeal templates and why they are deliberately unemotional Replied, post #21 · Access › Insurance & coverage · 3 Nov 2025 · 1 like Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a specification for an appeal. Reading the reason carefully and…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters — a second dataset Replied, post #3 · Compounds › Tirzepatide · 27 Oct 2025 · 1 like Picking up post #2: that is the part I would want checked first. Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that…
-
Sleep tracking data and its considerable limitations Replied, post #67 · Wellbeing › Sleep · 23 Oct 2025 · 18 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Research-use-only labelling: what it means and what it does not Replied, post #42 · Sourcing › Regulatory · 6 Oct 2025 · 9 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Retatrutide's phase 2 heart-rate signal and how to think about it Replied, post #5 · Compounds › Retatrutide · 29 Sep 2025 · 4 likes Picking up post #2: that is the part I would want checked first. Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison of tirzepatide…
-
Column chemistry choices for a 40-residue peptide Replied, post #42 · Analytics › HPLC & UHPLC · 21 Sep 2025 · 31 likes post #41 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #50 · Evidence › Study critique · 14 Sep 2025 · 4 likes Picking up post #47: that is the part I would want checked first. Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random…
-
Hepatic impairment and the absence of data Replied, post #32 · Clinical › Special populations · 11 Sep 2025 · 7 likes Worth separating two things that post #28 runs together. Hepatic impairment: less is known about dosing in significant liver disease than in kidney disease. Extreme…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #31 · Lounge › Off topic · 11 Sep 2025 · 19 likes Worth separating two things that post #27 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Second pass at: Coverage in the US: a map of the usual obstacles Replied, post #3 · Regional › North America · 10 Sep 2025 · 25 likes Prior authorisation, step therapy, and exclusion of weight-management indications from coverage are common access barriers. The denial letter tells you which barrier…
-
When a preprint is the best available evidence and we say so Replied, post #135 · Evidence › Preprints · 3 Sep 2025 · 28 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #109 · Compounds › Secretagogues & GH axis · 28 Aug 2025 · 0 likes Pulsatile secretion matters because growth hormone is secreted in pulses, not continuously. A single post-dose growth hormone level is nearly uninterpretable. Assessing…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #87 · Access › Insurance & coverage · 20 Aug 2025 · 0 likes Picking up post #84: that is the part I would want checked first. Reimbursement changes: a compound covered one year might not be the next. A formulary decision in…
-
Angle of injection and whether 90 degrees is always right Replied, post #10 · Practice › Administration · 13 Aug 2025 · 4 likes Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a reason to assume you lost a significant dose.…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #37 · Sourcing › Vendor reports · 9 Aug 2025 · 0 likes On post #33 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
A ten-fold dose error caught before injection — one year on Replied, post #113 · Devices › Syringes & needles · 4 Aug 2025 · 0 likes Picking up post #110: that is the part I would want checked first. Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible…
-
The C-cell question: rodent findings and their human context Replied, post #46 · Compounds › Semaglutide · 2 Aug 2025 · 9 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
-
Thyroid function tests during substantial weight change Replied, post #19 · Clinical › Bloodwork · 1 Aug 2025 · 8 likes I read post #17 twice before replying, because I had assumed the opposite. Renal function markers: eGFR is estimated, not measured. It depends on creatinine, age, and…
-
Subcutaneous absorption kinetics and site differences Replied, post #18 · Pharmacology › Pharmacokinetics · 27 Jul 2025 · 31 likes post #17 answers the question as asked. The question underneath it is different. Accumulation at steady state: with a week-long half-life, steady-state concentration is…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #59 · Evidence › Trials · 22 Jun 2025 · 1 like Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation method (was it truly random or could someone predict the next assignment),…
-
What a documentation review can and cannot tell you Replied, post #5 · Sourcing › Independent verification · 13 Jun 2025 · 16 likes post #4 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #48 · Evidence › Journal club · 30 May 2025 · 17 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #112 · Outcomes › Body composition · 28 May 2025 · 0 likes Worth separating two things that post #108 runs together. DXA (dual-energy X-ray absorptiometry): the standard for body composition in research. Precision is roughly ±1…
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #41 · Sourcing › Independent verification · 17 May 2025 · 0 likes On post #37 — agreed on the reasoning, with one qualification. Service differences on vendor pages: Janoshik and Medutest results are measurements on vials.…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #52 · Practice › Reconstitution · 13 May 2025 · 8 likes Coming back to post #50, because the follow-up matters more than the original answer. Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add…
-
A ten-fold dose error caught before injection Replied, post #26 · Devices › Syringes & needles · 27 Apr 2025 · 10 likes Picking up post #23: that is the part I would want checked first. Aspirating before injection: for subcutaneous injection, aspirating (pulling back on the plunger to…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #59 · Access › Pricing · 9 Apr 2025 · 11 likes post #58 answers the question as asked. The question underneath it is different. Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at…
-
Carryover and the ghost peak from last week's standard Replied, post #38 · Analytics › HPLC & UHPLC · 6 Apr 2025 · 0 likes Area percent is not mass percent. It is a proportion of absorbance, weighted by each species' extinction coefficient. For closely related impurities the approximation…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #90 · Evidence › Journal club · 4 Apr 2025 · 2 likes Picking up post #87: that is the part I would want checked first. SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a…
-
Adjudicated events and why the definition matters — the long version Replied, post #69 · Evidence › Trials · 28 Mar 2025 · 21 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #87 · Pharmacology › Receptor biology · 13 Mar 2025 · 7 likes Species differences: rodent studies show the same compounds produce effects in rodents that predict human effects reasonably well for semaglutide and tirzepatide. The…
-
Charge states for a 4 kDa peptide, worked through Replied, post #2 · Analytics › Mass spectrometry · 1 Mar 2025 · 8 likes Coming back to the opening post, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #6 · Practice › Reconstitution · 30 Jan 2025 · 5 likes Osmolarity and reconstitution: the osmolarity of the reconstituted solution affects comfort on injection. Isotonic solutions (close to blood osmolarity) are less…
-
When "no data" is the complete and final answer Replied, post #73 · Compounds › Other compounds · 23 Jan 2025 · 1 like Compounds this community declines to help with, and why: there are specifics in the guidelines and they are not arbitrary. They exist because of failure modes that have…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #35 · Compounds › Semaglutide · 22 Jan 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Fixed versus detachable needles: the trade-offs Replied, post #64 · Devices › Syringes & needles · 22 Dec 2024 · 5 likes On post #60 — agreed on the reasoning, with one qualification. Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #69 · Practice › Side effects · 13 Dec 2024 · 6 likes Worth separating two things that post #65 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #137 · Compounds › Repair & healing peptides · 24 Nov 2024 · 0 likes Analytical identity of BPC-157: a 15-residue peptide with an unambiguous mass (≈1419.5 Da). Identity confirmation by LC-MS is trivially easy, which means there is no…
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #18 · Nutrition & Training › Protein & intake · 23 Nov 2024 · 0 likes Protein supplements: whey, casein, and plant-based protein powders can help hit targets when whole-food intake is limited by appetite. Protein quality (all essential…
-
Requesting a page: what makes a good request — what changed since Replied, post #41 · Documentation › Wiki requests · 10 Oct 2024 · 0 likes Accessibility feedback: if you have trouble accessing or reading a maintained page (screen reader issues, contrast problems, small text) report it. Accessibility matters.
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #58 · Analytics › COA interpretation · 18 Sep 2024 · 17 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
-
When to suspect the method rather than the sample Replied, post #10 · Analytics › Method validation · 8 Sep 2024 · 1 like On post #6 — agreed on the reasoning, with one qualification. Robustness: the method gives consistent results when minor parameters vary. Tested by deliberately varying…
-
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #9 · Compounds › Retatrutide · 29 Aug 2024 · 5 likes post #8 answers the question as asked. The question underneath it is different. Why this subcategory is more cautious than elsewhere: retatrutide is investigational,…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #24 · Devices › Syringes & needles · 21 Aug 2024 · 25 likes Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL. Always confirm your syringe is U-100. Confusion between insulin units and…
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #6 · Compounds › Secretagogues & GH axis · 21 Aug 2024 · 0 likes This follows post #3 rather than contradicting it. Pulsatile secretion matters because growth hormone is secreted in pulses, not continuously. A single post-dose growth…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #24 · Clinical › Prescriber conversations · 21 Jul 2024 · 0 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
-
Follow-up: Dead volume across syringe and needle combinations Replied, post #9 · Devices › Syringes & needles · 13 Jul 2024 · 0 likes I read post #7 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
The mass-error checker and its intended scope Replied, post #99 · Data & Tools › Calculators · 5 Jul 2024 · 15 likes Reporting bugs: if you notice a calculator giving wrong results, report it in this subcategory. Bugs are fixed when identified.
-
How this community labels and discusses unrefereed work Replied, post #34 · Evidence › Preprints · 22 Jun 2024 · 21 likes Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
-
Assessing a warm arrival: the decision process — one year on Replied, post #31 · Sourcing › Logistics · 29 May 2024 · 0 likes This follows post #28 rather than contradicting it. Declaring contents accurately: declaring accurately reduces intervention risk. A declaration of "peptide research…